Search alternatives:
lower decrease » larger decrease (Expand Search), linear decrease (Expand Search), showed decreased (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
Showing 461 - 480 results of 8,630 for search 'significantly ((((((lower decrease) OR (we decrease))) OR (nn decrease))) OR (teer decrease))', query time: 0.58s Refine Results
  1. 461
    Correlation of lung function parameters with smoking variables.

    Correlation of lung function parameters with smoking variables. by Prasanna Herath (20714794)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 462
    Anthropometric characteristics of smokers and non-smokers.

    Anthropometric characteristics of smokers and non-smokers. by Prasanna Herath (20714794)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 463
    Respiratory clinical characteristics of smokers and non-smokers.

    Respiratory clinical characteristics of smokers and non-smokers. by Prasanna Herath (20714794)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 464
    Effect of the smoking factor on lung function parameters (FVC, FEV1, PEF, FEF 25_75).

    Effect of the smoking factor on lung function parameters (FVC, FEV1, PEF, FEF 25_75). by Prasanna Herath (20714794)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 465
    Lung function parameters between smokers and non-smokers.

    Lung function parameters between smokers and non-smokers. by Prasanna Herath (20714794)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 466
    Supplementary file 1_Global variation in antibiotic prescribing guidelines and the implications for decreasing AMR in the future.docx

    Supplementary file 1_Global variation in antibiotic prescribing guidelines and the implications for decreasing AMR in the future.docx by Emmama Jamil (22005635)

    Published 2025
    Save to List
    Saved in:
  7. 467
    Development of a CRISPR/Cas-Based Detection Platform for Tracking Decreased Susceptibility to Cephalosporins in Neisseria gonorrheae

    Development of a CRISPR/Cas-Based Detection Platform for Tracking Decreased Susceptibility to Cephalosporins in Neisseria gonorrheae by Ziyuan Zhao (2889005)

    Published 2025
    “…Developing efficient and accurate detection of resistant strains is urgently needed for their management and treatment. We have developed the Multiplex Integrated RPA-CRISPR/Cas12a detection Assay (MIRCA) for simultaneous detection of Neisseria gonorrheae (<i>Ng</i>) and mutations with decreased susceptibility to cephalosporins. …”
    Save to List
    Saved in:
  8. 468
    Descriptive statistics (means) for full sample and by lockdown status.

    Descriptive statistics (means) for full sample and by lockdown status. by Drew B. Cameron (10687420)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 469
    Study sites and number of participants enrolled in the KAP and OOP surveys.

    Study sites and number of participants enrolled in the KAP and OOP surveys. by Drew B. Cameron (10687420)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 470
    Average cost per visit for HIV and HTN care (absolute vs. relative contributions).

    Average cost per visit for HIV and HTN care (absolute vs. relative contributions). by Drew B. Cameron (10687420)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 471
    GLM models for predictors of monthly HTN care costs.

    GLM models for predictors of monthly HTN care costs. by Drew B. Cameron (10687420)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 472
    Median monthly care costs, projected visits, and hospitalization costs.

    Median monthly care costs, projected visits, and hospitalization costs. by Drew B. Cameron (10687420)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  13. 473
    Study Flowchart.

    Study Flowchart. by Jae-Heung Cho (798319)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 474
    Changes in outcomes over time.

    Changes in outcomes over time. by Jae-Heung Cho (798319)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 475
    Study timetable.

    Study timetable. by Jae-Heung Cho (798319)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 476
    Cumulative incidence curves of recovery by group.

    Cumulative incidence curves of recovery by group. by Jae-Heung Cho (798319)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 477
    Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n 

    Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 478
    Weekly resistance training frequency over time for the DHA and placebo groups combined (n 

    Weekly resistance training frequency over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 479
    Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups.

    Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. by Claire M. Douglas (21238238)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 480
    Participant demographic and clinical characteristics.

    Participant demographic and clinical characteristics. by Claire M. Douglas (21238238)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: